Overview

Study of Cryoablation and Nirogacestat for Desmoid Tumor

Status:
RECRUITING
Trial end date:
2028-02-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this protocol is Systemic therapy with oral study agent, nirogacestat, followed by a single cryoablation procedure.
Phase:
PHASE2
Details
Lead Sponsor:
Nam Bui
Collaborator:
SpringWorks Therapeutics, Inc.
Treatments:
Cryosurgery
nirogacestat